Goethe University Frankfurt — Frankfurt

Public research footprint of Goethe University Frankfurt, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Anal Cancer Stage III · Melanoma · Chronic Hepatitis D Infection · Ulcerative Colitis, Unspecified

Recently updated registry entries

NCT07280585 — STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease (Recruiting)
NCT05958121 — IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid… (Recruiting)
NCT07454837 — Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Goethe University Frankfurt?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.